1 min read

Pharma Giant Sanofi Delivers First Flu Shots of the Season

Featured Image

This past Monday, leading pharmaceutical company Sanofi Pasteur shipped out roughly 70 million doses of its latest flu vaccines for the upcoming 2018-2019 season. Headquartered in Pennsylvania, the company's massive order was comprised of three different variations of their latest flu vaccines: Fluzone Quadrivalent, Fluzone High-Dose, and Flublok Quadrivalent.

Still a few months out from the start of this upcoming flu season, the pharma giant is getting shipments out early to providers as they anticipate another severe season, much like last year’s. Sanofi has three variations of flu vaccines to help protect all ages:

1. Flu Quadrivalent is administered for people 6 months of age or older and helps fight four strains of the virus (two A and two B)

2. Flublok Quadrivalent is a protein-based dosage intended for those who are 18 and older and can be especially effective for those aged 50 and above

3. Fluzone High-Dose is designed to help those 65 years of age and older in preventing pneumonia, cardiorespiratory, and other flu-associated hospitalizations


For those who would rather not depend on home remedies or medicine from a pharmacy to prevent influenza, the flu vaccine is an extremely common option. While the flu vaccine has shown to be very effective in many cases, influenza remains in the top 10 leading causes of death in the country. This preemptive move by Sanofi Pasteur hopes to avoid an outbreak like 2017-2018.